Literature DB >> 17874711

Scottish Medicines Consortium: an overview of rapid new drug assessment in Scotland.

J Dear1, C O'Dowd, A Timoney, K R Paterson, A Walker, D J Webb.   

Abstract

Mesh：

Year:  2007        PMID： 17874711     DOI： 10.1258/rsmsmj.52.3.20

Source DB:  PubMed          Journal:  Scott Med J        ISSN： 0036-9330            Impact factor:   0.729


× No keyword cloud information.
  5 in total

Review 1.  International comparison of comparative effectiveness research in five jurisdictions: insights for the US.

Authors:  Adrian R Levy; Craig Mitton; Karissa M Johnston; Brian Harrigan; Andrew H Briggs
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  An investigation into the effect of advice from the Scottish Medicines Consortium on the use of medicines in Scotland's Health Service.

Authors:  Marion Bennie; James Dear; Sharon Hems; Corri Black; Laura McIver; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

3.  UK medicines policy: the role of clinical pharmacologists.

Authors:  David J Webb
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

4.  Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations.

Authors:  Linda Björkhem-Bergman; Eva Andersén-Karlsson; Richard Laing; Eduardo Diogene; Oyvind Melien; Malena Jirlow; Rickard E Malmström; Sabine Vogler; Brian Godman; Lars L Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

5.  NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium.

Authors:  John A Ford; Norman Waugh; Pawana Sharma; Mark Sculpher; Andrew Walker
Journal:  BMJ Open       Date:  2012-01-30       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.